- IN₹502.06bn
- IN₹470.57bn
- IN₹64.31bn
India Stocks: Indian shares poised to rebound as Fed-hike fears, oil prices ease
Brief: Gland Pharma Approves $21 Million Investment In Gland Pharma Usa
Brief: Fosun Pharma Says Unit Sold Gland Pharma Shares for $294 Mln
India's Gland Pharma gains on successful completion of US FDA probe at Visakhapatnam plant
Brief: Gland Pharma Says USFDA Concludes Inspection At Co’S Visakhapatnam Facilities
Brief: Gland Pharma Says Deepak Sapra Appointed As CEO Effective November 16, 2026
India's Gland Pharma rises after upbeat profit as analysts cheer on new products, contracts
India's Gland Pharma beats quarterly profit view on strong Europe, US sales
Brief: Gland Pharma Gets Tax Order Of 35.3 Million Rupees And Penalty Of 35.3 Million Rupees
India's Gland Pharma jumps to 10-month high on quarterly profit surge
Brief: Gland Pharma Receives Tentative USFDA Approval For Brimonidine Tartrate Ophthalmic Solution
Brief: Gland Pharma Says CEO Shyamakant Giri Resigns Effective April 30, 2026
India's Gland Pharma hits more than 2-month high on strong Q3 results
India's Gland Pharma posts higher quarterly profit on strong US, Europe demand
Brief: Gland Pharma Q3 Consol Net Profit 2.61 Billion Rupees vs IBES Est. 2.44 Billion Rupees
India's Gland Pharma rises after US FDA approval for drug application
Brief: Gland Pharma Receives USFDA Approval For Olopatadine Solution
India's Gland Pharma posts higher quarterly profit on Cenexi boost
Brief: Gland Pharma Sept-Quarter Consol Net Profit 1.84 Billion Rupees